Skip to main content

Table 7 Qualitative representation of individual benefits of using the app: scores before and after app use

From: Development, feasibility testing and perceived benefits of a new app to help with adherence to antiretroviral therapy in people living with HIV in Brazil

  

Participants

 

Variables

 

1

2

3

4

5

6

7

8

9

10

11

Number (%) of participants that improved

Compliance (CEAT-VIH)

Pretest

15

13

15

8

14

13

13

15

13

11

15

4 out of 11 (36%)

Posttest

14

15

14

7

11

15

15

15

15

10

13

Antecedents of nonadherence (CEAT-VIH)

Pretest

17

19

18

14

20

15

18

16

20

20

20

3 out of 11 (27%)

Posttest

16

19

20

15

20

20

17

16

20

20

20

Treatment satisfaction (CEAT-VIH)

Pretest

9

2

8

8

7

8

7

6

10

9

10

4 out of 11 (36%)

Posttest

9

6

9

4

7

9

7

10

9

9

10

Doctor–patient communications (CEAT-VIH)

Pretest

15

6

14

9

11

14

14

15

15

10

15

2 out of 11 (18%)

Posttest

14

8

14

11

11

14

15

15

14

9

14

Personal beliefs and expectations about treatment (CEAT-VIH)

Pretest

25

16

20

17

21

20

19

25

19

25

22

7 out of 11 (64%)

Posttest

25

20

21

18

19

21

24

25

23

23

25

Global adherence score (total score of the CEAT-VIH)

Pretest

81

56

75

56

73

70

71

77

77

75

82

6 out of 11 (54%)

Posttest

78

68

78

55

68

79

78

81

81

71

82

Well-being (WHO-5)

Pretest

14

3

14

12

9

6

4

3

15

8

7

7 out of 11 (64%)

Posttest

15

1

14

5

10

12

12

7

14

12

12